Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer.
about
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyDesign and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificityTwo sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells.Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.Choline metabolism in malignant transformation.Phospholipase D: enzymology, functionality, and chemical modulationPhysiological and pathophysiological roles for phospholipase D.Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasionPhospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.A Single Nucleotide Polymorphism in the Phospholipase D1 Gene is Associated with Risk of Non-Small Cell Lung Cancer.The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion.Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis.Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cellsPhosphatidic acid, phospholipase D and tumorigenesis.Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.Chemical modulation of glycerolipid signaling and metabolic pathways.Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.Targeting Phospholipid Metabolism in Cancer.Targeting phospholipase D in cancer, infection and neurodegenerative disorders.Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells.Alternative phospholipase D/mTOR survival signal in human breast cancer cells.Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D.Phospholipase D and Its Essential Role in Cancer.Pharmacophore modelling, virtual screening and molecular docking studies on PLD1 inhibitors.Fate of Liposomes in the Presence of Phospholipase C and D: From Atomic to Supramolecular Lipid Arrangement
P2860
Q24635853-216DD9AC-3C3B-40C6-B58D-E29EC237D6DEQ27015257-F0596356-E9ED-44A4-B2B1-D5CBEF9E60F9Q28237443-61DABAFD-ADD0-459A-BD0E-2F019B050EF2Q30370046-F0D1E1B6-971E-4EC3-AB48-C9C2A7D78C8EQ30851391-34424EF3-61FD-443B-AB71-1A5DF464B028Q33399066-2F1394A7-17A6-4AC5-AB53-3C36FBB0C7B1Q33658578-DC2278C5-C284-4F57-A6B8-D7C2206A1CA5Q33678025-EA55B6BB-B997-47A7-AB41-A84841EF9C77Q34044522-403CA0EF-F624-4920-BD90-37F9AE987877Q34085728-4F0779BA-16E0-4E0E-B14C-B57FED865A66Q35112040-404977DD-12C5-4636-A83A-551456BE1E50Q35599714-86D0E52F-D3FE-4783-A6FC-4D6D627DBF9FQ36307313-AC6B5345-E7A9-49B4-866C-7252E76D6AB1Q36442381-BB06847B-1A0B-49BF-9B0E-1BB544D0069FQ36597889-51E3EDF2-48EB-4DBD-9361-F3ECCAEAA08AQ36732919-255371DC-69CE-4F12-8BFE-A91FEBEDE3A7Q36735743-A8FB464B-C92E-4D44-9602-13AB82C39140Q36909364-5E2C5DBA-3743-47E2-93AB-E44AD58F46B2Q37041152-D3D8CC0B-8BAB-46F8-9553-00BF52862704Q37380645-9B5F1DD0-69B3-4DD2-BDD8-C44C34A8111FQ37546020-985C9313-E679-4B03-BA47-94927DBAA7DAQ37624626-6641CF59-8D26-40C2-AD52-57FB3D0CC38CQ37630591-B74BE13B-B61C-4E5B-AB66-D887BF89651FQ37665324-6EC6DEDF-83AF-41F4-B280-D46DE1E810EAQ38179801-B834F596-A2C3-4E02-A02D-D24F9F0EEEE1Q38816137-51B64FCF-1533-46A0-8F5F-1A033AB705CDQ38937084-CE74F175-6BE3-43DD-ADBB-5112FCDBB425Q39084885-830DAEA9-524B-49A5-9519-FC2F440E4425Q39139780-944552AA-4BEA-4572-B639-1422149DDFAEQ39187790-665B4893-773A-4C85-9F27-12C4D836543AQ40484574-F0F381DC-F1E1-4E09-8EEB-EA8485B19336Q42689280-0542C397-75AE-48B3-AC07-455CDAC1FAA9Q45335240-BA782DCB-B9E9-4212-8558-B2760A295240Q47096624-FAF45494-B578-4E5A-B790-2CC140CC3661Q47587655-F72EFC90-D4BE-4D22-B73A-91420B4D6937Q56894018-EBA9DA69-EE60-4FB1-B4E3-361DD3921713
P2860
Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Association of a polymorphism ...... evalence of colorectal cancer.
@en
Association of a polymorphism ...... evalence of colorectal cancer.
@nl
type
label
Association of a polymorphism ...... evalence of colorectal cancer.
@en
Association of a polymorphism ...... evalence of colorectal cancer.
@nl
prefLabel
Association of a polymorphism ...... evalence of colorectal cancer.
@en
Association of a polymorphism ...... evalence of colorectal cancer.
@nl
P2093
P2860
P1476
Association of a polymorphism ...... evalence of colorectal cancer.
@en
P2093
Hiroji Iwata
Hitoshi Yoshida
Kazuo Tajima
Masashi Tanaka
Masayuki Shinoda
Motokazu Suyama
Nobuyuki Hamajima
Suzuno Kusakabe
Tetsuya Mitsudomi
Tomoyuki Kato
P2860
P2888
P304
P356
10.1007/S00109-002-0411-X
P577
2003-02-11T00:00:00Z
P6179
1046436712